Gareb B, van Bakelen N B, Buijs G J, Jansma J, de Visscher J G A M, Hoppenreijs Th J M, Bergsma J E, van Minnen B, Stegenga B, Bos R R M
Department of Oral and Maxillofacial Surgery, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Department of Oral and Maxillofacial Surgery, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.
PLoS One. 2017 May 11;12(5):e0177152. doi: 10.1371/journal.pone.0177152. eCollection 2017.
Biodegradable fixation systems could reduce or eliminate problems associated with titanium removal of implants in a second operation.
The aim of this study was to compare the long-term (i.e. >5 years postoperatively) clinical performance of a titanium and a biodegradable system in oral and maxillofacial surgery.
The present multicenter Randomized Controlled Trial (RCT) was performed in four hospitals in the Netherlands. Patients treated with a bilateral sagittal split osteotomy (BSSO) and/or a Le Fort-I osteotomy, and those treated for fractures of the mandible, maxilla, or zygoma were included from December 2006 to July 2009. The patients were randomly assigned to either a titanium (KLS Martin) or a biodegradable group (Inion CPS).
After >5 years postoperatively, plate removal was performed in 22 of the 134 (16.4%) patients treated with titanium and in 23 of the 87 (26.4%) patients treated with the biodegradable system (P = 0.036, hazard ratio (HR) biodegradable (95% CI) = 2.0 (1.05-3.8), HR titanium = 1). Occlusion, VAS pain scores, and MFIQ showed good and (almost) pain free mandibular function in both groups.
In conclusion, the performance of the Inion CPS biodegradable system was inferior compared to the KLS Martin titanium system regarding plate/screws removal in the abovementioned surgical procedures.
http://controlled-trials.com ISRCTN44212338.
可生物降解固定系统可减少或消除二次手术中取出钛植入物相关的问题。
本研究旨在比较钛和可生物降解系统在口腔颌面外科手术中的长期(即术后>5年)临床性能。
本多中心随机对照试验(RCT)在荷兰的四家医院进行。纳入2006年12月至2009年7月期间接受双侧矢状劈开截骨术(BSSO)和/或勒福I型截骨术治疗的患者,以及治疗下颌骨、上颌骨或颧骨骨折的患者。患者被随机分为钛(KLS Martin)组或可生物降解组(Inion CPS)。
术后>5年,134例接受钛治疗的患者中有22例(16.4%)进行了钢板取出,87例接受可生物降解系统治疗的患者中有23例(26.4%)进行了钢板取出(P = 0.036,可生物降解组风险比(HR)(95%CI)= 2.0(1.05 - 3.8),钛组HR = 1)。两组的咬合、视觉模拟评分(VAS)疼痛评分和下颌功能指数问卷(MFIQ)均显示下颌功能良好且(几乎)无疼痛。
总之,在上述手术中,就钢板/螺钉取出而言,Inion CPS可生物降解系统的性能不如KLS Martin钛系统。
http://controlled-trials.com ISRCTN44212338 。